Provided by Tiger Fintech (Singapore) Pte. Ltd.

BEIGENE

229.000
+16.4007.71%
Volume:9.98M
Turnover:2.27B
Market Cap:352.89B
PE:-62.56
High:229.400
Open:222.400
Low:221.600
Close:212.600
52wk High:229.400
52wk Low:103.100
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:1.72
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-3.661
ROE:1.81%
ROA:1.69%
PB:11.00
PE(LYR):-62.56
PS:9.13

Loading ...

Industrial Securities: Structure More Important Than Timing in Healthy Bull Market, Seeking Opportunities Through Prosperity-Anchored Expansion

Stock News
·
Sep 15

China Securities Co., Ltd.: Innovative Drug Globalization Drives Pharmaceutical Industry Chain Recovery

Stock News
·
Sep 13

BEIGENE: Total of 63,000 American Depositary Shares Purchased by 3,932 Participants Under 2018 Employee Stock Purchase Plan

Deep News
·
Sep 13

Policy Uncertainty Fails to Dampen Long-Term Innovation Drug Prospects as Institutions Remain Optimistic

Stock News
·
Sep 12

BEIGENE (06160) Issues 818,500 Shares Due to Stock Option Exercises

Stock News
·
Sep 12

Capital Group Increases Stake in BEIGENE (06160) by Approximately 882,600 Shares at HK$348.12 per Share

Stock News
·
Sep 11

BUZZ-Hansoh leads slide in HK-listed biotech shares on report of US curbs

Reuters
·
Sep 11

HK Movers | Biotech Stocks Plunge. Ascletis Pharma down 14%; Clover Bio, Transcenta down over 10%; Beigene, HBM Holdings down over 8%; Jacobio down over 7%

Tiger Newspress
·
Sep 11

Trump Administration Plans to Restrict Chinese Pharmaceuticals, BEIGENE Stock Plunges 12%

Deep News
·
Sep 10

BeiGene's WCLC Data Shines! Hong Kong Stock Connect Innovative Drug ETF (520880) with 100% Purity Trades at High Premium! Institutions: Innovation Drug Bull Market May Be Far from Over

Deep News
·
Sep 10

BeiGene to Sell Up to 4 Million Shares in Employee Share Purchase Plan

MT Newswires Live
·
Sep 04

BeiGene (06160): New Subscription Period for 2018 Employee Stock Purchase Plan Runs from September 2 to February 27, 2026

Stock News
·
Sep 04

Major Index Adjustments: Two Popular Bull Stocks Added

Deep News
·
Sep 04

FTSE China A50 Index Quarterly Review: Adds BeiGene (688235.SH), Wuxi Apptec Co.,Ltd. (603259.SH), Removes China National Nuclear Power Co.,Ltd. (601985.SH) and Others

Stock News
·
Sep 03

US Stock Movement | BeiGene (ONC.US) Surges Over 9% as H1 2025 Revenue Grows 46%

Stock News
·
Sep 02

HK Movers|Biopharmaceutical Stocks Rallied. BeiGene up 9%; 3SBio And Tigermed Up Over 4%; Wuxi XDC Increasing More Than 3%

Tiger Newspress
·
Sep 02

BEIGENE (06160): Sonrotoclax Achieves Positive Clinical Results for Treating Mantle Cell Lymphoma Patients

Stock News
·
Aug 29

BeOne Medicines Turns to H1 Profit

MT Newswires Live
·
Aug 28

Hong Kong Stock Morning Brief | 166 Domestic Games Approved in August, China Ruyi (00136) Reports Double Growth in H1 Revenue and Profit

Stock News
·
Aug 26

CCB International Maintains Cautious Optimism on Chinese Pharmaceutical Stocks Despite High Valuations, Assigns "Outperform" Rating to BeiGene (06160)

Stock News
·
Aug 14